Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?
- DOI
- 10.1080/10428190903040030
- Published
- 2009-08-01
- Container
- Leuk Lymphoma
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/10428190903040030,
title = {Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?},
author = {Geisler C and Kolstad A and Laurell A and Räty R and Nordic Lymphoma Group and Mantle Cell Lymphoma Subcommittee.},
year = {2009},
journal = {Leuk Lymphoma},
doi = {10.1080/10428190903040030},
url = {https://doi.org/10.1080/10428190903040030}
}RIS
TY - JOUR TI - Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients? AU - Geisler C AU - Kolstad A AU - Laurell A AU - Räty R AU - Nordic Lymphoma Group AU - Mantle Cell Lymphoma Subcommittee. PY - 2009 JO - Leuk Lymphoma DO - 10.1080/10428190903040030 UR - https://doi.org/10.1080/10428190903040030 ER -
APA
C, G., A, K., A, L., R, R., Group, N. L., & Subcommittee., M. C. L. (2009). Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?. Leuk Lymphoma. https://doi.org/10.1080/10428190903040030
Source records
- europe-pmc · retrieved 2026-09-26T09:17:04.888Z